Global artificial tears market is anticipated to grow at a CAGR of 6.2% during the forecast period (2024–2031). Artificial tears are formulated as eye drops to hydrate dry eyes and retain moisture on the eye's outer surface. The market growth is driven by the rising prevalence of Dry Eye Syndrome (DES) in the geriatric population, which increases susceptibility to ophthalmic disorders. Furthermore, the increased use of contact lenses, digital workloads, and ongoing product innovations are creating future growth opportunities for the market.
Browse the full report description of “Artificial Tears Market Size, Share & Trends Analysis Report by Type (Cellulose Derived Tears, Glycerin Derived, Oil Based Emulsion Tears, and Polyethylene Glycol and Propylene Glycol-Based Tears), by Delivery Method (Eye Drops, And Ointments), and by Application (Dry Eyes Treatment, And Contact Lenses Moisture) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/artificial-tears-market
Recent Developments
Market Coverage
· The market number available for 2023-2031
· Base year: 2023
· Forecast period: 2024-2031
· Segment Covered-
o By Type
o By Delivery Method
o By Application
· Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape: Bayer AG., Johnson & Johnson Surgical Vision, Inc., and Novartis International AG among others.
Key questions addressed by the report
Global Artificial Tears Market Report Segment
By Type
By Delivery Method
By Application
Global Artificial Tears Market Report Segment by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Italy
· Spain
· France
· Rest of Europe
Asia-Pacific
· China
· India
· Japan
· South Korea
· Rest of Asia-Pacific
Rest of the World
· Latin America
· Middle East and Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/artificial-tears-market